Addex Therapeutics Ltd. (ADXN)
7.71
+0.03
(+0.39%)
USD |
NASDAQ |
Dec 30, 10:35
Addex Therapeutics Research and Development Expense (Quarterly): 0.2853M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 505.41M |
| AC Immune SA | 16.33M |
| CRISPR Therapeutics AG | 54.50M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 10.41M |